Engaged Capital 13F holdings, Q2 2016
Holdings as of June 30, 2016 · filings on SEC EDGAR · latest filing →
Engaged Capital disclosed 12 US equity positions worth $284.2m in its Q2 2016 13F filing. The largest position was OUTERWALL INC at 35.9% of the reported book, followed by BHE and ROVI CORP. Against the Q1 2016 filing, it opened 1 new position, added to 2 and reduced 2 among the top 12 holdings.
What did Engaged Capital own in Q2 2016? Top 12 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2016 |
|---|---|---|---|---|---|---|---|
| 1 | OUTERWALL INC | 35.9% | $102.1m | 2,431,170 | 0% | held | |
| 2 | BHE BENCHMARK ELECTRS INC | Technology | 18.1% | $51.4m | 2,428,221 | 0% | held |
| 3 | ROVI CORP | 13.5% | $38.3m | 2,450,000 | 9% | added | |
| 4 | MED MEDIFAST INC | Consumer Cyclical | 8.6% | $24.5m | 737,465 | 0% | held |
| 5 | MX MAGNACHIP SEMICONDUCTOR CORP | Technology | 7.7% | $21.8m | 3,852,974 | 0% | held |
| 6 | JAMBA INC | 6.6% | $18.8m | 1,830,767 | 0% | held | |
| 7 | TRS TRIMAS CORP | Consumer Cyclical | 4.3% | $12.2m | 679,067 | 0% | held |
| 8 | LBYYQ LIBBEY INC | 1.6% | $4.7m | 293,064 | 9% | added | |
| 9 | IWM ISHARES TR | 1.6% | $4.5m | 39,569 | -30% | reduced | |
| 10 | BIODELIVERY SCIENCES INTL IN | 1.6% | $4.4m | 1,876,550 | 0% | held | |
| 11 | AMAG AMAG PHARMACEUTICALS INC | 0.4% | $1.2m | 50,174 | -24% | reduced | |
| 12 | STKL SUNOPTA INC | 0.1% | $220.0k | 52,593 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.